(Q39438457)

English

The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

0 references

0 references

cancer cell line

1 reference

based on heuristic

inferred from title

author name string

Carole Brosseau

1

1 reference

Europe PubMed Central

12 September 2017

Kay Colston

2

1 reference

Europe PubMed Central

12 September 2017

Angus George Dalgleish

3

1 reference

Europe PubMed Central

12 September 2017

Christine Galustian

4

1 reference

Europe PubMed Central

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2012

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

17

1 reference

Europe PubMed Central

12 September 2017

2

1 reference

Europe PubMed Central

12 September 2017

164-173

1 reference

Europe PubMed Central

12 September 2017

https://scigraph.springernature.com/pub.10.1007/s10495-011-0670-5

0 references

Vitamin D receptor as a drug discovery target

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Cancer chemoprevention using natural vitamin D and synthetic analogs

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Vitamin D and vitamin D analogs as cancer chemopreventive agents

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Targets of vitamin D receptor signaling in the mammary gland

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs).

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Mediation of cell death by poly(ADP-ribose) polymerase-1.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

MCF-7/VD(R): a new vitamin D resistant cell line

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Bcl-2 inhibitors: small molecules with a big impact on cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0670-5

21 January 2018

Identifiers

10.1007/S10495-011-0670-5

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39438457&oldid=1967171324"